Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Charmacy Pharmaceutical Co., Ltd. Class H ( (HK:2289) ) just unveiled an announcement.
Charmacy Pharmaceutical Co., Ltd. announced its unaudited consolidated interim results for the six months ended June 30, 2025. The company reported a decline in operating revenue by 8.18% to RMB 2,155,071,000 and a decrease in net profit attributable to shareholders by 18.72% to RMB 21,739,000 compared to the same period in 2024. This decline in financial performance reflects challenges in the market and may impact the company’s positioning and stakeholder interests.
More about Charmacy Pharmaceutical Co., Ltd. Class H
Charmacy Pharmaceutical Co., Ltd. is a joint stock limited liability company incorporated in the People’s Republic of China, operating in the pharmaceutical industry. The company is listed on the Hong Kong Stock Exchange and focuses on providing pharmaceutical products and services.
Average Trading Volume: 42,140
Technical Sentiment Signal: Sell
Current Market Cap: HK$629.6M
Find detailed analytics on 2289 stock on TipRanks’ Stock Analysis page.